Successes and reference projects

Substantial contribution to 6 successful Market Authorization and New Drug Applications of Voltaren Forte®, Lamisil Once®, Alvesco® MDI, Omnaris®, Libobay®, and Trasylol®

Particular expertise in Clinical Development, Medical Affairs and Patient Safety with the successful conduct of > twenty Phase II-IV trials and transition of seven products from the preclinical into the clinical stage

Management of medical benefit-risk deliverables during a major crisis to the satisfaction of the local Health Authority resulting in a de-escalation of relationship

Led integration of 3 separate Pharmacovigilance (PV) systems into one of the world`s largest single PV system

Spearheaded R&D delivery of innovation-focused, sustainable portfolios across Pharma and Consumer Health business models

Leadership of different transformational change initiative minimising attrition of personnel